Christopher Chin

Christopher Chin has a diverse work experience in the medical field. Christopher currently holds the position of Growth Director at Privia Health since March 2023. Prior to this, they worked as a Sales Representative at Stryker from December 2021 to March 2023. Before joining Stryker, Christopher served as the President of C2 Medical Innovations, Inc. from December 2017 to December 2022. In this role, they represented various orthopedic and biological products. Additionally, Christopher has experience working at Smith & Nephew as an Orthopedic Sales Representative from July 2013 to December 2021 and as an Associate Sales Representative from May 2012 to July 2013. During their tenure at Smith & Nephew, they achieved high performance rankings and played a key role in managing accounts and achieving sales quotas for their territory.

Christopher Chin completed their Master of Business Administration (MBA) from Saint Mary's College of California from 2021 to 2023. Prior to that, they pursued their Bachelor of Science (B.S) in General Biology at UC San Diego from 2007 to 2010.